Parenchyma-Sparing Robotic Sleeve Resection of the Left Lower Lobe Bronchus
This excellent video demonstrates a patient with recurrent pneumonia due to an obstructing left lower lobe bronchial neuroendocrine tumor without metastasis. #cancer
🔗https://t.co/nuteeEkK5y
As Dr Motoko Tachihara underlined clearly the aim of multimodality approach is to achieve cure or disease control via whether straight forward surgery or salvage surgery whether neoadjuvant or definitive chemo-IO. @AATSHQ
Dr @TokerAlper discussed the effect of TKI treatment prior to lung resection in the era of personalized multidisciplinary cancer treatment options. @AATSHQ
It was great to share expertise here and wide. @AATSHQ One of our robotic bronchial sleeve resection case presents such an example. A big chance to participate in these robotic cases as well as these high-level global meetings with @TokerAlper
Discussing in Boston MA, the pros and cons of new neoadjuvant treatment options. NEOADAURA trial promises less upstaging and more downstaging compared to chemo alone in patients with stage II and IIIB EGFRm NSCLC. @AATSHQ
@ibrahimsarbay Modern tıbbın dayanağı olarak kabul edilen literatür için büyük tehlike. Yakın tarihte en büyük dergilerde bile retrakte edilen onlarca makale oldu. Tıbbi literatür balon gibi şişiriliyor mu acaba? Sonuçta bunlar daha Scopusta indekslenen yayınlar.
Türkiye Acil Tıp Vakfı 3. Uluslararası Acil Tıp Kongresi Next Generation İngilizce bilimsel sunum yarışmasında 3.’lük ödülü aldım.
Just won the Bronze Award in Türkiye Emergency Medicine Foundation Next Generation scientific presentation contest.
Does segmentectomy really helps preverving lung functions better, what about local recurrence, survival rates, treatments… The future lies ahead of us. Multimodality approach should be key, that’s for sure!
@TokerAlper , Dominique Gossot, Tim Batchelor and Wentao Fang discussed the rational behind lung cancer resection: Lobectomy vs segmentectomy, why and why not…
at Turkish Thoracic Surgery Conference